Pharmaceutical giant Merz has won an injunction from Europe's patent court to stop generic drugmaker Viatris Santé from selling a multiple sclerosis treatment in France for two more months while Merz's intellectual property rights are still in force.
Pharmaceutical giant Merz has won an injunction from Europe's patent court to stop generic drugmaker Viatris Santé from selling a multiple sclerosis treatment in France for two more months while Merz's intellectual property rights are still in force.
Europe's top court ruled Thursday that retirement homes do not need extra licenses to retransmit TV and radio broadcasts to residents, finding that sharing those programs through an internal cable system does not breach the bloc's copyright law.
A Swiss sports marketing company has failed to convince the Unified Patent Court that a rival has infringed its patent for a way of overlaying digital billboards in television broadcasts.
Novartis has persuaded an appeals panel to uphold its European patent covering blockbuster heart disease drug Entresto, fighting off arguments from numerous generics companies that the treatment isn't inventive.
Novo Nordisk has obtained an inadvertent win against a rival's patent for a method of modifying antibodies in the blood, after the Japanese pharmaceutical company told European appellate officials that it no longer approved of the claims.
House of IP, a newly launched consultancy, said Thursday that it has acquired patent prosecution firm Patentwerk BV, marking the first step in its plan to build a broader network of intellectual property businesses across Europe.
